Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAMI Acadian Asset Management	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$44.51 +4.5%	$43.00 ➝ $48.00	In-Line
AB AllianceBernstein	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Dunn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.81 -1.6%	$46.00 ➝ $44.00	Outperform
ADBE Adobe	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$348.97 +1.4%	$567.00 ➝ $460.00	Overweight
ADM Admiral Group	Downgraded by	Peel Hunt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,342 -3.0%	GBX 2,270 ➝ GBX 2,350	Sell
AET Afentra	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 54.40		Buy
AG First Majestic Silver	Target Raised by	Cormark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$12.69 +1.2%	C$14.00 ➝ C$17.50
AGX Argan	Target Raised by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$211.39 -11.1%	$236.00 ➝ $260.00	Buy
AI C3.ai	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.58 +0.7%	$28.00 ➝ $16.00	Hold
ALGM Allegro MicroSystems	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.57 +1.6%	$45.00 ➝ $38.00	Buy
ALNY Alnylam Pharmaceuticals	Target Set by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kostas Biliouris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$452.00 -0.3%	$470.00	Outperform
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
APAM Artisan Partners Asset Management	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Dunn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.32 -1.4%	$43.00 ➝ $45.00	In-Line
APP AppLovin	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Heaney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$490.24 -1.9%	$560.00 ➝ $615.00	Buy
ASML ASML	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Francois-Xavier Bouvignies Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$781.70 +3.8%		Neutral ➝ Buy
AVDL Avadel Pharmaceuticals	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.76 +5.1%	$24.00 ➝ $36.00	Buy
AVGO Broadcom	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Stein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$295.00 ➝ $365.00	Buy
AVGO Broadcom	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Schafer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$325.00 ➝ $360.00	Outperform
AVGO Broadcom	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Rakesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$320.00 ➝ $355.00	Outperform
AVGO Broadcom	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Danely Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$315.00 ➝ $350.00	Buy
AVGO Broadcom	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$255.00 ➝ $345.00	Equal Weight
AVGO Broadcom	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stacy Rasgon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$295.00 ➝ $400.00	Outperform
AVGO Broadcom	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harsh Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$315.00 ➝ $375.00	Overweight
AVGO Broadcom	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cody Acree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$315.00 ➝ $385.00	Buy
AVGO Broadcom	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Cassidy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$340.00 ➝ $400.00	Buy
AVGO Broadcom	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$300.00 ➝ $400.00	Buy
AVGO Broadcom	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harlan Sur Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$325.00 ➝ $400.00	Overweight
AVGO Broadcom	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross Seymore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$300.00 ➝ $350.00	Buy
AVGO Broadcom	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$334.89 +9.4%	$355.00 ➝ $370.00	Buy
AVGO Broadcom	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Vinh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$330.00 ➝ $400.00	Overweight
AVGO Broadcom	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom O'Malley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.89 +9.4%	$265.00 ➝ $400.00	Overweight
AVTX Avalo Therapeutics	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.60 +14.2%		Buy
AXP American Express	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Donald Fandetti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$326.37 -1.3%	$350.00 ➝ $375.00	Overweight
BA BAE Systems	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,777 +0.9%		Overweight
BAB Babcock International Group	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,091 +2.2%	GBX 1,350 ➝ GBX 1,360	Buy
BAP Credicorp	Downgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carlos Gomez-Lopez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.23 +0.5%	$225.00 ➝ $255.00	Buy ➝ Hold
BASE Couchbase	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Dietz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.44	$20.00 ➝ $24.50	Neutral
BASE Couchbase	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Howard Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.44	$26.00	Buy ➝ Neutral
BBCP Concrete Pumping	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Wittmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.64 +12.2%	$6.00 ➝ $6.50	Neutral
BDGI Badger Infrastructure Solutions	Target Set by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$57.74 +2.1%	C$70.00	Buy
BDT Bird Construction	Target Raised by	ATB Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$26.24 +0.9%	C$30.00 ➝ C$33.00	Outperform
BDT Bird Construction	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$26.24 +0.9%	C$34.00 ➝ C$36.00	Buy

BDT Bird Construction	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$26.24 +0.9%	C$31.00 ➝ C$32.00	Buy
BK Bank of New York Mellon	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.69 -1.8%	$92.00 ➝ $105.00	Neutral
BLK BlackRock	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glenn Schorr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,099.21 -0.9%	$1,170.00 ➝ $1,200.00	Outperform
BMO Bank Of Montreal	Upgraded by	Cibc World Mkts Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$126.10 +0.7%		Hold ➝ Strong-Buy
BMO Bank Of Montreal	Upgraded by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$126.10 +0.7%		Neutral ➝ Sector Outperform
BMO Bank of Montreal	Upgraded by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$174.72 +0.9%	C$173.00 ➝ C$180.00	Neutral ➝ Outperform
BMO Bank of Montreal	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$174.72 +0.9%	C$180.00 ➝ C$185.00	Buy
BMO Bank of Montreal	Upgraded by	Cibc World Mkts Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$174.72 +0.9%		Hold ➝ Strong-Buy
BNS Bank of Nova Scotia	Target Raised by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$87.86 +0.0%	C$90.00 ➝ C$93.00	Neutral
BRZE Braze	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucky Schreiner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$40.00	Buy
BRZE Braze	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$50.00	Buy
BRZE Braze	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Bracelin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$38.00 ➝ $50.00	Overweight
BRZE Braze	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Macwilliams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$35.00 ➝ $39.00	Overweight
BRZE Braze	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$43.00	Buy
BRZE Braze	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$50.00 ➝ $52.00	Buy
BRZE Braze	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$40.00 ➝ $45.00	Outperform
BRZE Braze	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor McGinnis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$48.00 ➝ $43.00	Buy
BRZE Braze	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$68.00	Market Outperform
BRZE Braze	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Vanvliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.42 +13.6%	$35.00 ➝ $38.00	Overweight
BTRW Barratt Redrow	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 367.40 +2.0%	GBX 565	Buy
BYDDY BYD	Downgraded by	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.41 +0.8%		Buy ➝ Hold
CABA Cabaletta Bio	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Schimmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.70 +10.4%	$15.00	Overweight
CANG Cango	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Dede Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.07 +7.2%	$8.00	Buy
CART Maplebear	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.29 +1.9%	$55.00 ➝ $57.00	Equal Weight
CBZ CBIZ	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$59.86 -0.2%		Outperform
CCC Computacenter	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,294 -1.3%	GBX 2,700	Buy
CCK Crown	Upgraded by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Roxland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.20 +2.1%	$118.00	Hold ➝ Buy
CELH Celsius	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gerald Pascarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.37 -3.9%	$60.00 ➝ $70.00	Buy
CGON CG Oncology	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.07 +6.9%	$75.00	Buy
CHA Chagee	Initiated by	Macquarie Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Linda Huang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.07 -4.3%	$19.00	Neutral
CHPT ChargePoint	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mickey Legg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.19	$40.00 ➝ $20.00	Buy
CIEN Ciena	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Vogt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.57 -0.3%	$78.00 ➝ $120.00	Neutral
CIEN Ciena	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samik Chatterjee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.57 -0.3%	$105.00 ➝ $140.00	Overweight
CIEN Ciena	Reiterated by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dave Kang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.57 -0.3%	$90.00 ➝ $113.00	Buy ➝ Neutral
CIEN Ciena	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tal Liani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.57 -0.3%	$95.00 ➝ $135.00	Buy
CIEN Ciena	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Genovese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.57 -0.3%	$100.00 ➝ $127.50	Neutral
CIEN Ciena	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Koontz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.57 -0.3%	$90.00 ➝ $130.00	Buy
CIEN Ciena	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jim Kelleher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.57 -0.3%	$100.00 ➝ $135.00	Buy
CIEN Ciena	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.57 -0.3%	$70.00 ➝ $100.00	Underweight
CIEN Ciena	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tim Long Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$116.57 -0.3%	$102.00 ➝ $138.00	Overweight
CJT Cargojet	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$103.04 +3.4%	C$132.00	Outperform
CLX Clorox	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Carey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.08 +2.0%	$138.00 ➝ $130.00	Equal Weight
CMG Chipotle Mexican Grill	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Saleh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.04 -0.9%	$57.00	Buy
CNC Centene	Target Lowered by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.97 +1.1%	$40.00 ➝ $36.00	Outperform
CNS Cohen & Steers	Target Lowered by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Dunn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.46 -0.3%	$79.00 ➝ $77.00	Outperform
COLD Americold Realty Trust	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg McGinniss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.95 +0.2%	$20.00 ➝ $16.00	Sector Perform
CPB Campbell's	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Megan Alexander Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.03 +4.2%	$32.00 ➝ $33.00	Equal Weight
CPRT Copart	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Lick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.57 -2.8%	$50.00 ➝ $46.00	Equal Weight
CRBG Corebridge Financial	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.66 +0.1%	$47.00 ➝ $46.00	Overweight
CRMT America's Car-Mart	Target Lowered by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Joseph Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.12 -1.1%	$67.00 ➝ $45.00	Overweight

CUBI Customers Bancorp	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kelly Motta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$67.45 -3.6%	$71.00 ➝ $76.00	Market Perform
CURV Torrid	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lorraine Hutchinson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.81 -23.8%	$7.00 ➝ $6.00	Buy
CURV Torrid	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Janine Stichter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.81 -23.8%		Neutral
CVS CVS Health	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.76 +0.1%	$72.00 ➝ $77.00	Market Perform
DASH DoorDash	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$246.85 -0.8%	$280.00 ➝ $306.00	Equal Weight
DAVA Endava	Reiterated by	Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.14 +1.7%		Hold
DAVA Endava	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.14 +1.7%	$20.00 ➝ $12.00	Buy
DAVA Endava	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.14 +1.7%	$20.00 ➝ $18.00	Buy
DAVA Endava	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.14 +1.7%	$17.00 ➝ $11.00	Equal Weight
DLB Dolby Laboratories	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$72.56 -0.3%		Hold
DLB Dolby Laboratories	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.56 -0.3%	$74.00	Neutral
DLTH Duluth	Upgraded by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Komp Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.79 +5.6%	$2.00 ➝ $7.00	Neutral ➝ Outperform
DLTH Duluth	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.79 +5.6%		Hold ➝ Strong-Buy
DLTR Dollar Tree	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$101.12 +0.9%	$96.00 ➝ $105.00	Equal Weight
DNLM Dunelm Group	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,225 +2.3%	GBX 1,385	Buy
DOCU Docusign	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%	$80.00 ➝ $85.00	Equal Weight
DOCU Docusign	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%	$124.00	Market Outperform
DOCU Docusign	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%	$80.00 ➝ $85.00	Neutral
DOCU Docusign	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%	$85.00 ➝ $90.00	Neutral
DOCU Docusign	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%	$85.00 ➝ $102.00	Neutral
DOCU Docusign	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%	$90.00 ➝ $95.00	Sector Perform
DOCU Docusign	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%	$77.00 ➝ $80.00	Neutral
DOCU Docusign	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%		Hold
DOCU Docusign	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kirk Materne Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%	$90.00 ➝ $92.00	In-Line
DOCU Docusign	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Power Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.86 +4.7%	$85.00 ➝ $90.00	Neutral
DOOO BRP	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$65.50 +0.1%	$35.00 ➝ $70.00	Neutral
DUOL Duolingo	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$271.18 -0.6%		Hold
DUOL Duolingo	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$271.18 -0.6%	$280.00	Neutral
ECL Ecolab	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Wittmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$273.56 -0.5%	$300.00 ➝ $306.00	Outperform
EDIT Editas Medicine	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.76 +9.5%	$5.00	Buy
ELV Elevance Health	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$313.79 +1.9%	$435.00 ➝ $425.00	Buy
EOSE Eos Energy Enterprises	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Osha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.21 -1.8%	$6.00 ➝ $10.00	Buy
EOSE Eos Energy Enterprises	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.21 -1.8%	$6.50	Hold
EPAC Enerpac Tool Group	Initiated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom Hayes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.66 +0.7%	$48.00	Buy
EQX Equinox Gold	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$7.88 -0.9%	C$13.00 ➝ C$15.00	Buy
ESAB ESAB	Initiated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom Hayes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.94 +1.3%	$150.00	Buy
ETOR eToro Group	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Allen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.40 +0.5%	$62.00 ➝ $57.00	Neutral
FCFS FirstCash	Downgraded by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Chukumba Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.13 -2.5%	$145.00	Buy ➝ Hold
FDS FactSet Research Systems	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Haas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.94 +0.4%	$405.00 ➝ $355.00	Underweight
FDX FedEx	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Ossenbeck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$227.43 +1.0%	$290.00 ➝ $285.00	Overweight
FHI Federated Hermes	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Dunn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.76 -1.5%	$48.00 ➝ $55.00	Outperform
FIZZ National Beverage	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.01 -3.2%	$45.00 ➝ $40.00	Sell
FNMA Fannie Mae	Initiated by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Randy Binner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.60 +1.9%	$10.00	Neutral
GEV GE Vernova	Target Raised by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean McLoughlin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$581.92 -2.8%	$570.00 ➝ $580.00	Hold
GIII G-III Apparel Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Kearney Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.96 -6.0%	$18.00 ➝ $21.00	Underweight
GIII G-III Apparel Group	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ashley Owens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.96 -6.0%	$30.00 ➝ $33.00	Overweight
GOOGL Alphabet	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$235.00 +1.2%	$240.00 ➝ $280.00	Strong-Buy
GPE Great Portland Estates	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 300 +1.4%	GBX 510	Buy
GTLB GitLab	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.73 +5.2%	$55.00 ➝ $52.00	Outperform
GTLB GitLab	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan McKeveny Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$45.73 +5.2%	$47.00 ➝ $44.00	Equal Weight

GWRE Guidewire Software	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Wong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.32 +20.4%	$275.00 ➝ $300.00	Outperform
GWRE Guidewire Software	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.32 +20.4%	$290.00 ➝ $300.00	Outperform
GWRE Guidewire Software	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.32 +20.4%	$270.00 ➝ $300.00	Buy
GWRE Guidewire Software	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Vruwink Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.32 +20.4%	$270.00 ➝ $288.00	Outperform
GWRE Guidewire Software	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Hotchkiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.32 +20.4%	$270.00 ➝ $305.00	Buy
GWRE Guidewire Software	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.32 +20.4%	$265.00 ➝ $275.00	Overweight
GWRE Guidewire Software	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Sklar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.32 +20.4%	$255.00 ➝ $275.00	Outperform
HAYW Hayward	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	W. Andrew Carter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.25 +1.5%	$17.50 ➝ $18.00	Buy
HCAT Health Catalyst	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.38 +2.4%		Neutral
HEI Heico	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Epstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$322.49 +0.1%	$355.00 ➝ $400.00	Buy
HLIO Helios Technologies	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey D. Hammond Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$55.38 +1.6%	$45.00 ➝ $61.00	Overweight
HNGE Hinge Health	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.90 -2.0%		Hold
HNGE Hinge Health	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$54.90 -2.0%	$56.00	Neutral
HR Healthcare Realty Trust	Upgraded by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Yulico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.04 +3.1%	$18.00 ➝ $20.00	Sector Perform ➝ Sector Outperform
HSBC HSBC	Upgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$65.58 +0.8%		Underperform ➝ Outperform
HUM Humana	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$307.94 -1.3%	$275.00 ➝ $315.00	Equal Weight
HUM Humana	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$307.94 -1.3%	$269.00 ➝ $341.00	Outperform
IMNM Immunome	Initiated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Vogel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.52 +7.3%	$26.00	Buy
IOT Samsara	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Hedberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.16 +17.6%	$44.00 ➝ $46.00	Outperform
IOT Samsara	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Junaid Siddiqui Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.16 +17.6%	$35.00 ➝ $39.00	Hold
IOT Samsara	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.16 +17.6%	$47.00 ➝ $48.00	Overweight
IOT Samsara	Upgraded by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Stoss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.16 +17.6%	$42.00 ➝ $48.00	Hold ➝ Buy
IOT Samsara	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Jester Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.16 +17.6%	$54.00 ➝ $47.00	Outperform
IVZ Invesco	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glenn Schorr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.97 +0.1%	$23.00 ➝ $24.00	In-Line
JBHT J.B. Hunt Transport Services	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.73 -1.1%	$155.00 ➝ $157.00	Buy ➝ Neutral
JBLU JetBlue Airways	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.08 -0.2%	$3.00 ➝ $4.00	Sell
JHG Janus Henderson Group	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Dunn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.29 -1.8%	$45.00 ➝ $48.00	In-Line
KNX Knight-Swift Transportation	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.13 -2.2%	$46.00 ➝ $51.00	Buy ➝ Neutral
KRMN Karman	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Gesuale Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.52 +17.1%	$100.00	Strong-Buy
LCID Lucid Group	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Sheppard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.41 +13.9%	$20.00	Neutral
LECO Lincoln Electric	Initiated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom Hayes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$244.32 +0.1%	$279.00	Buy
LGIH LGI Homes	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$67.01 +2.4%	$95.00	Neutral
LINE Lineage	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg McGinniss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.59 +0.3%	$49.00 ➝ $43.00	Sector Perform
LION Lionsgate Studios	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$6.17 -0.5%		Strong-Buy
LION Lionsgate Studios	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.17 -0.5%	$8.00	Outperform
LUCD Lucid Diagnostics	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Massaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.37 -0.7%	$2.00 ➝ $2.50	Buy
LULU lululemon athletica	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Nagel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$500.00	Outperform ➝ Market Perform
LULU lululemon athletica	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Nagel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%		Outperform ➝ Market Perform
LULU lululemon athletica	Target Lowered by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aneesha Sherman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$350.00 ➝ $220.00	Outperform
LULU lululemon athletica	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$220.00 ➝ $190.00	Neutral
LULU lululemon athletica	Target Lowered by	TD Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$167.80 -18.6%	$298.00 ➝ $220.00	Buy
LULU lululemon athletica	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$240.00 ➝ $185.00	Neutral
LULU lululemon athletica	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$205.00 ➝ $160.00	Equal Weight
LULU lululemon athletica	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$209.00 ➝ $180.00	Equal Weight
LULU lululemon athletica	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Boss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$224.00 ➝ $191.00	Neutral
LULU lululemon athletica	Target Lowered by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brooke Roach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$232.00 ➝ $200.00	Neutral
LULU lululemon athletica	Downgraded by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$167.80 -18.6%	$170.00	Buy ➝ Hold
LULU lululemon athletica	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anna Andreeva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$200.00 ➝ $165.00	Neutral
LULU lululemon athletica	Reiterated by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Binetti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$265.00 ➝ $180.00	Outperform ➝ In-Line
LULU lululemon athletica	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$360.00 ➝ $200.00	Outperform ➝ Market Perform

LULU lululemon athletica	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom Nikic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$238.00 ➝ $192.00	Buy
LULU lululemon athletica	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lorraine Hutchinson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$300.00 ➝ $210.00	Buy ➝ Neutral
LULU lululemon athletica	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Janine Stichter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$375.00 ➝ $303.00	Buy
LULU lululemon athletica	Downgraded by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sharon Zackfia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%		Outperform ➝ Market Perform
LULU lululemon athletica	Reiterated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jim Duffy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$324.00 ➝ $205.00	Buy ➝ Hold
LULU lululemon athletica	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Altschwager Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$167.80 -18.6%	$260.00 ➝ $225.00	Outperform
LYFT Lyft	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.66 -0.8%	$15.00 ➝ $16.00	Equal Weight
MARA Marathon Digital	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Lewis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.19 +0.5%	$27.00	Buy
MAX MediaAlpha	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tommy McJoynt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.41 +3.6%	$17.00 ➝ $18.00	Outperform
MD Pediatrix Medical Group	Target Raised by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.06 +0.3%	$14.50 ➝ $17.00	Market Perform
MNKD MannKind	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andreas Argyrides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.54 +3.7%	$12.00 ➝ $15.00	Outperform
MOH Molina Healthcare	Target Lowered by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$174.51 +2.2%	$284.00 ➝ $220.00	Outperform
MOON Moonpig Group	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 195	GBX 360	Buy
MUSA Murphy USA	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bradley Thomas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$386.27 +3.4%		Overweight
MVIS Microvision	Reiterated by	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Casey Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.11 +0.9%	$2.00	Buy
NA National Bank of Canada	Target Raised by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$145.91 +1.0%	C$151.00 ➝ C$154.00	Neutral
NBIX Neurocrine Biosciences	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Abrahams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$144.10 +2.6%	$144.00 ➝ $149.00	Outperform
NBIX Neurocrine Biosciences	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Hung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$144.10 +2.6%	$158.00 ➝ $163.00	Overweight
NGVT Ingevity	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John McNulty Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$59.69 +1.4%	$62.00 ➝ $68.00	Outperform
NI NiSource	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Dumoulin-Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.35 +1.3%	$48.00 ➝ $44.00	Buy ➝ Hold
NTR Nutrien	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.39 -1.0%	$64.00	Sector Perform
NTR Nutrien	Initiated by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$56.39 -1.0%		Sector Perform
NTRS Northern Trust	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Emily Ericksen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.27 -1.7%	$110.00 ➝ $135.00	Neutral
NU NU	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Domingos Falavina Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.75 -0.8%	$16.00 ➝ $17.00	Overweight
NWG NatWest Group	Downgraded by	BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.78 -2.0%		Hold ➝ Strong Sell
NWG NatWest Group	Downgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.78 -2.0%		Neutral ➝ Underperform
NXT NEXT	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		£122.45 +1.2%	£142	Buy
OMDA Omada Health	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.28 +2.4%	$24.00	Neutral
OMDA Omada Health	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.28 +2.4%		Hold
ON ON Semiconductor	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.10 +2.2%	$56.00 ➝ $52.00	Neutral
OXM Oxford Industries	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.14 -1.1%	$52.00	Market Perform
PAAS Pan American Silver	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ovais Habib Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.60 +3.0%	$36.50 ➝ $36.00	Sector Outperform ➝ Outperform
PAAS Pan American Silver	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$47.91 +3.1%	C$38.00 ➝ C$45.00
PAAS Pan American Silver	Target Raised by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$47.91 +3.1%	C$52.50 ➝ C$62.00	Outperform
PATH UiPath	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry Tillman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.50 +6.0%	$13.00 ➝ $12.00	Hold
PATH UiPath	Initiated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucky Schreiner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.50 +6.0%	$14.00 ➝ $12.00	Neutral
PATH UiPath	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.50 +6.0%		Hold
PATH UiPath	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.50 +6.0%	$15.50 ➝ $12.50	Market Perform
PHNX Phoenix Group	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 669 +1.3%	GBX 630	Neutral
PHR Phreesia	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Close Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.09 -10.0%	$34.00 ➝ $38.00	Buy
PHR Phreesia	Initiated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lucky Schreiner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.09 -10.0%	$33.00	Buy
PHR Phreesia	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.09 -10.0%	$33.00 ➝ $34.00	Overweight
PHR Phreesia	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$28.09 -10.0%	$29.00 ➝ $35.00	Buy
PM Philip Morris International	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Faham Baig Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$161.61 +0.3%	$177.00 ➝ $166.00	Neutral
PSKY Paramount Skydance	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Reif Ehrlich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$15.00 +1.8%	$11.00	Underperform
QURE uniQure	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.95 +1.2%	$70.00	Buy
QXO QXO	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sam Darkatsh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$22.03 +6.7%	$28.00	Outperform
RARE Ultragenyx Pharmaceutical	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristen Kluska Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.82 +1.7%	$105.00	Overweight
RCEL Avita Medical	Target Lowered by	D. Boral Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Kolbert Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.26 -0.7%	$18.00 ➝ $14.00	Buy
RLJ RLJ Lodging Trust	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Miller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$7.86 +0.7%	$7.00 ➝ $8.00	Hold
RR Rolls-Royce Holdings plc	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 1,075.50 +0.6%		Overweight
RSW Renishaw	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,225 +1.6%	GBX 3,900	Buy
RVMD Revolution Medicines	Initiated by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Asthika Goonewardene Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$40.50 +4.0%	$99.00	Buy
RY Royal Bank of Canada	Downgraded by	Cibc World Mkts Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$200.22 -0.7%		Strong-Buy ➝ Hold
RY Royal Bank of Canada	Downgraded by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$200.22 -0.7%	C$208.00	Outperform ➝ Neutral
RY Royal Bank Of Canada	Downgraded by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$144.58 -0.8%		Sector Outperform ➝ Neutral
RY Royal Bank Of Canada	Downgraded by	Cibc World Mkts Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$144.58 -0.8%		Strong-Buy ➝ Hold
SAIC Science Applications International	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Siegmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.93 -1.2%	$130.00 ➝ $128.00	Buy
SAIC Science Applications International	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gavin Parsons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.93 -1.2%	$111.00 ➝ $110.00	Neutral
SEPN Septerna	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Schimmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.43 +2.2%	$25.00	Overweight
SG Sweetgreen	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.94 +2.2%		Outperform
SGD Snowline Gold	Target Set by	National Bankshares Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$10.79 +6.4%	C$15.00	Outperform
SGSOY SGS	Upgraded by	BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.66 +4.8%		Hold ➝ Strong-Buy
SNDR Schneider National	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.56 -0.9%	$25.00 ➝ $26.00	Buy ➝ Neutral
SNDX Syndax Pharmaceuticals	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Corinne Johnson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.04 +5.3%	$20.00 ➝ $24.00	Buy
SPG Simon Property Group	Reiterated by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Ferguson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$182.05 +0.3%	$185.00	Buy
SPWH Sportsman's Warehouse	Target Raised by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Smith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.38 +12.3%	$3.00 ➝ $3.50	Buy
STRZ Starz Entertainment	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$12.60 -2.7%		Hold
STRZ Starz Entertainment	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.60 -2.7%	$13.00	Neutral
STT State Street	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Emily Ericksen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$112.99 -0.9%	$115.00 ➝ $130.00	Neutral ➝ Buy
TD Toronto-Dominion Bank	Target Raised by	CIBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$103.16 -0.2%	C$109.00 ➝ C$112.00
TJX TJX Companies	Initiated by	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$139.30 -1.2%		Buy
TKO TKO Group	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$193.75 +1.9%	$225.00	Outperform
TKO TKO Group	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$193.75 +1.9%		Strong-Buy
TLW Tullow Oil	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 10.83 +6.6%		Buy
TOL Toll Brothers	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Graja Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.24 +1.3%	$150.00 ➝ $165.00	Buy
TOL Toll Brothers	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay McCanless Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.24 +1.3%	$165.00	Outperform
TRN Trainline	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 267 +1.3%	GBX 465	Buy
TROW T. Rowe Price Group	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glenn Schorr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$108.16 -3.0%	$110.00 ➝ $115.00	In-Line
TRP TC Energy	Target Set by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$71.83 +1.1%	C$75.00	Neutral
TRST Trustpilot Group	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 205.80 +3.6%	GBX 400	Buy
TSLA Tesla	Reiterated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$350.84 +3.6%		Market Perform
TTAN ServiceTitan	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terry Tillman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.99 +13.6%	$120.00 ➝ $130.00	Buy
TTAN ServiceTitan	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.99 +13.6%	$125.00 ➝ $130.00	Overweight
TTAN ServiceTitan	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.99 +13.6%	$140.00	Buy
TTAN ServiceTitan	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Bracelin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.99 +13.6%	$150.00 ➝ $155.00	Overweight
TTAN ServiceTitan	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Parker Lane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.99 +13.6%	$125.00 ➝ $135.00	Buy
TTAN ServiceTitan	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Baer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.99 +13.6%	$109.00 ➝ $118.00	Equal Weight
TTAN ServiceTitan	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Vruwink Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$113.99 +13.6%	$124.00 ➝ $130.00	Outperform
TTC Toro	Target Raised by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Shlisky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.68 +1.3%	$93.00 ➝ $97.00	Buy
TTC Toro	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Wojs Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.68 +1.3%	$82.00 ➝ $86.00	Neutral
TWLO Twilio	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$108.60 +2.4%	$140.00	Buy
TXN Texas Instruments	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vivek Arya Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$187.93 +0.3%	$218.00 ➝ $208.00	Neutral
UBER Uber Technologies	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ken Gawrelski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.89 -1.2%	$119.00 ➝ $127.00	Overweight
ULVR Unilever	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 4,769 -0.7%	GBX 4,120	Sell
UNH UnitedHealth Group	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$315.10 +1.5%	$337.00 ➝ $379.00	Outperform
UTHR United Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$400.52 +5.3%	$400.00 ➝ $500.00	Buy
UTHR United Therapeutics	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andreas Argyrides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$400.52 +5.3%	$510.00 ➝ $575.00	Outperform
VFS VinFast Auto	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James McIlree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.34 +0.3%	$5.50	Buy
VFS VinFast Auto	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Sheppard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.34 +0.3%	$6.00	Overweight
VTY Vistry Group	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 621.02 +3.6%	GBX 450	Sell
WAY Waystar	Initiated by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.27 +0.1%	$44.00	Outperform
WAY Waystar	Upgraded by	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.27 +0.1%		Strong-Buy
WCC WESCO International	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Glynn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$219.61 +0.6%	$225.00 ➝ $255.00	Outperform
WPC W.P. Carey	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Yulico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$68.07 +1.8%	$64.00 ➝ $67.00	Sector Perform
ZUMZ Zumiez	Target Raised by	B. Riley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Van Sinderen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$21.31 +15.5%	$14.00 ➝ $18.00	Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:03 AM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings